RC
BOLD

RBF Capital’s Boundless Bio BOLD Stock Holding History

RBF Capital’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$220K Hold
200,000
– – 0.01% 450
2025
Q4 		$240K Hold
200,000
– – 0.01% 499
2025
Q3 		$246K Hold
200,000
– – 0.01% 501
2025
Q2 		$202K Buy
+200,000
New +$266K 0.01% 536

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

RBF Capital's BOLD Position: Q1 2026 in Review

RBF Capital held its Boundless Bio (BOLD) position steady in Q1 2026 at 200,000 shares worth $220K. The position accounts for 0.01% of the portfolio, ranked #450.

RBF Capital first reported a position in BOLD in Q2 2025 and has held it in 4 quarters since. The position peaked at $246K in Q3 2025. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • RBF Capital held 200,000 shares of Boundless Bio worth $220K as of Q1 2026.
  • RBF Capital left its Boundless Bio share count unchanged in Q1 2026.
  • Boundless Bio made up 0.01% of RBF Capital's portfolio in Q1 2026, its #450 holding.
  • RBF Capital first reported a position in Boundless Bio in Q2 2025 and has held it in 4 quarters since.
  • RBF Capital's Boundless Bio position peaked at $246K in Q3 2025.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on RBF Capital's 13F filing for Q1 2026, filed 15 May 2026.